Indefinite Delivery Contract SPE2DU25D1060

Award Date 8/1/25
Last Date to Order 12/31/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The subject Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 contract, running through December 2036, serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical...
The provided information describes an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 IDC, which runs through December 2036, serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses a broad...
The Indefinite Delivery Contract (IDC) SPE2DR25D3013, awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to AmerisourceBergen Drug Corp, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The $999,999,999 IDC has a period of performance through December 2026 and serves as a primary vehicle for the DLA to procure critical medical commodities, including specialty medications, brand-name...
The Indefinite Delivery Contract (IDC) SPE2DR25D3802 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs,...
The Indefinite Delivery Contract (IDC) SPE2DR25D2208 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $999,999,999 contract has a performance period through December 2036 and serves as a vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC encompasses critical medical commodities including...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide worldwide pharmaceutical support to various DoD customers. The contract has a $499,999,999 ceiling value and a period of performance through December 31, 2036. The contracted products and services encompass a comprehensive range of pharmaceutical and medical supplies, including specialty...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 contract, with a period of performance through December 2036, serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses...
The Indefinite Delivery Contract (IDC) SPE2DR25D1104 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a $9,999,999,999 ceiling value and runs through December 31, 2036. It serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC encompasses critical medical...
The Indefinite Delivery Contract (IDC) SPE2DU25D5133 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,999,999, has an ultimate completion date of December 31, 2036 and covers the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC is part of the...
The Indefinite Delivery Contract (IDC) SPE2DR25D1906 was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $999,999,999 contract, which runs through 2036, is part of the DLA Troop Support Medical Pharmaceutical Prime Vendor Global Program Generation V. Under this IDC, Amerisourcebergen will provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including...

The Indefinite Delivery Contract (IDC) SPE2DU25D1060 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $4,999,999 and runs through December 31, 2036.

This IDC serves as a vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract will enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined, comprehensive contracting mechanism. This acquisition is an unrestricted, fully competitive procurement with a Lowest Price Technically Acceptable (LPTA) evaluation strategy, and the government intends to make multiple regional awards to ensure resiliency of the pharmaceutical supply chain.

Generated 6/6/25, 9:45 AM